Sarah L. Harden1,2,3†
Jieliang Zhou4†
Seley Gharanei1,5Maria Diniz-da-Costa1,6
Emma S. Lucas1,7
Liang Cui2Keisuke Murakami8Jinling Fang2
Qingfeng Chen3
Jan J. Brosens1,6,7
Yie Hou Lee2,4,9*- 1Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, University of Warwick, Coventry, United Kingdom
- 2Singapore–MIT Alliance for Research and Technology, Singapore, Singapore
- 3Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore
- 4Translational ‘Omics and Biomarkers Group, KK Research Centre, KK Women’s and Children’s Hospital, Singapore, Singapore
- 5Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom
- 6Tommy’s National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
- 7Centre for Early Life, Warwick Medical School, University of Warwick, Coventry, United Kingdom
- 8Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo, Japan
- 9Obstetrics and Gynaecology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Differentiation of endometrial fibroblasts into specialized decidual cells controls embryo implantation and transforms the cycling endometrium into a semi-permanent, immune-protective matrix that accommodates the placenta throughout pregnancy. This process starts during the midluteal phase of the menstrual cycle with decidual transformation of perivascular cells (PVC) surrounding the terminal spiral arterioles and endometrial stromal cells (EnSC) underlying the luminal epithelium. Decidualization involves extensive cellular reprogramming and acquisition of a secretory phenotype, essential for coordinated placental trophoblast invasion. Secreted metabolites are an emerging class of signaling molecules, collectively known as the exometabolome. Here, we used liquid chromatography-mass spectrometry to characterize and analyze time-resolved changes in metabolite secretion (exometabolome) of primary PVC and EnSC decidualized over 8 days. PVC were isolated using positive selection of the cell surface marker SUSD2. We identified 79 annotated metabolites differentially secreted upon decidualization, including prostaglandin, sphingolipid, and hyaluronic acid metabolites. Secreted metabolites encompassed 21 metabolic pathways, most prominently glycerolipid and pyrimidine metabolism. Although temporal exometabolome changes were comparable between decidualizing PVC and EnSC, 32 metabolites were differentially secreted across the decidualization time-course. Further, targeted metabolomics demonstrated significant differences in secretion of purine pathway metabolites between decidualized PVC and EnSC. Taken together, our findings indicate that the metabolic footprints generated by different decidual subpopulations encode spatiotemporal information that may be important for optimal embryo implantation.
Introduction
Cyclical decidualization, i.e., differentiation of endometrial fibroblasts into specialized decidual cells, is a hallmark of menstruating mammals (Brosens et al., 2009; Emera et al., 2012). Rather than being triggered by an implanting embryo, decidualization in menstruating species is initiated during the midluteal phase of each cycle in response to sustained progesterone signaling and rising intracellular cyclic adenosine monophosphate (cAMP) levels (Gellersen and Brosens, 2014). Initially, decidual changes are most prominent in sushi domain-containing 2-positive (SUSD2+) cells surrounding the terminal spiral arterioles and in SUSD2− stromal cells underlying the luminal epithelium (Murakami et al., 2014), and then spread to encompass the entire stromal compartment (Gellersen and Brosens, 2014). In parallel, proliferating innate immune cells accumulate, foremost uterine natural killer cells (Brighton et al., 2017). Upon embryo implantation, decidualizing cells rapidly encapsulate the conceptus (Weimar et al., 2012; Berkhout et al., 2018), engage in embryo biosensing and selection (Brosens et al., 2014; Macklon and Brosens, 2014), and then form an immune-privileged decidual matrix that controls interstitial and intravascular trophoblast invasion (Nancy et al., 2012; Erlebacher, 2013; Gellersen and Brosens, 2014).
Recent studies have shown that decidualization is a multistep differentiation process, which starts with an evolutionarily conserved acute cellular stress response (Erkenbrack et al., 2018; Stadtmauer and Wagner, 2020), characterized by a burst of reactive oxygen species (ROS) production and release of proinflammatory cytokines (Al-Sabbagh et al., 2011; Salker et al., 2012; Brighton et al., 2017; Lucas et al., 2020). After a lag period of several days, differentiating cells lose their fibroblastic appearance and emerge as secretory decidual cells with abundant cytoplasm and prominent endoplasmic reticulum (Gellersen and Brosens, 2014). At a molecular level, the decidual transformation of endometrial fibroblasts involves genome-wide remodeling of the chromatin landscape (Vrljicak et al., 2018) extensive reprogramming of multiple signal transduction and metabolic pathways (Leitao et al., 2010; Muter et al., 2016, 2018) and activation of decidual gene networks (Takano et al., 2007; Cloke et al., 2008; Mazur et al., 2015). Decidualization of EnSC has been associated with alterations in respiration and mitochondrial metabolism (Ryu et al., 2020). At a functional level, decidualization transforms endometrial fibroblasts into secretory cells that are anti-inflammatory (Kuroda et al., 2013; Lucas et al., 2020), resistant to stress signals (Kajihara et al., 2006; Leitao et al., 2010; Lucas et al., 2020), and highly responsive to embryonic cues (Teklenburg et al., 2010; Brosens et al., 2014).
The decidual secretome is highly dynamic. Its composition changes across the different phases of the decidual pathway (Salker et al., 2012; Lucas et al., 2016, 2020) and the amplitude of the secretory response depends on the topography of cells in the native tissue (Murakami et al., 2014). For example, analysis of paired SUSD2− and SUSD2+ cell cultures demonstrated that perivascular SUSD2+ cells secrete significantly higher levels of various chemokines and cytokines, including chemokine (C-C motif) ligand 7 (CCL7) and leukemia inhibitory factor (LIF) (Murakami et al., 2014). These observations indicate that topographical microenvironments and chemokine gradients are established upon decidualization, which likely promote and direct trophoblast migration toward the spiral arterioles. Initially, invasion of the vessels results in plugging of these arteries by trophoblast. This facilitates conceptus development under low oxygen conditions, shielded from various environmental stressors. Notably, RNA-sequencing demonstrated that SUSD2 + stromal cells highly express genes encoding prototypic pericyte markers, including platelet-derived growth factor receptor (PDGFRB), CD146 (MCAM), neural/glial antigen 2 (CSPG4), and α smooth muscle actin (ACTA2) (Armulik et al., 2011; Ferland-McCollough et al., 2017). Hence, hereafter SUSD2+ cells are termed perivascular cells (PVC) whereas SUSD2− stromal cells are referred to as endometrial stromal cells (EnSC). On average 6 and 94% of non-immune stromal cells isolated from midluteal biopsies are PVC and EnSC, respectively (Lucas et al., 2016).
The metabolome encompasses a plethora of small organic molecules below 1.5 kDa with diverse physical and chemical structures, including nucleosides, amino acids, carbohydrates, and lipids (Cui et al., 2018). Exometabolomics, also known as metabolic footprinting, is the study of how cells transform their surrounding microenvironment through the secretion of metabolites. Exometabolomics have been used to study the secreted metabolome profile of micro-organisms, with mammalian exometabolomics being a nascent field (Birkenstock et al., 2012; Su et al., 2016). To date, exometabolomics has been performed to understand differences in profile of breast cancer cell lines, T-cell immunity, and stem cells (Ferreiro-Vera et al., 2011; Garcia-Manteiga et al., 2011; Matta et al., 2017). However, the exometabolome has not been established during decidualization. We hypothesize that specific temporally regulated secreted metabolites rapidly change upon decidualization, and that PVC and EnSC have distinct exometabolomes thereby establishing distinct microenvironmental niches.
In this study, we used both untargeted and targeted LC-MS exometabolomics to map the dynamic changes in the metabolic footprints of 12 paired PVC and EnSC cultures decidualized over an 8-day time-course.
Materials and Methods
Patient Selection and Endometrial Tissue Collection
The study was approved by the NHS National Research Ethics – Hammersmith and Queen Charlotte’s and Chelsea Research Ethics Committee (1997/5065). Endometrial biopsies from 12 patients were obtained in the Implantation Clinic, a specialized research clinic at University Hospitals Coventry and Warwickshire National Health Service Trust. Written informed consent was given by all participants in accordance with The Declaration of Helsinki 2000. Endometrial biopsies, timed 6 to 10 days following the preovulatory luteinizing hormone surge, were taken using a Wallach EndocellTM sampler (Wallach, Trumbull, United States) following a transvaginal ultrasound scan to exclude overt uterine pathology. Further, none of the participants had been prescribed hormonal treatment in at least 3 months prior to biopsy. Demographic details are summarized in Supplementary Table 1.
Isolation of PVC and EnSC From Endometrial Biopsies
Single-cell suspensions of EnSC were isolated from 12 midluteal biopsies as described previously (Masuda et al., 2012). In short, samples were collected in DMEM/F-12 with 10% dextran coated charcoal activated fetal bovine serum (DCC-FBS), finely chopped, and enzymatically digested with deoxyribonuclease type I (0.1 mg/mL; Roche, Burgess Hill, United Kingdom) and collagenase (0.5 mg/mL; Sigma-Aldrich, Gillingham, United Kingdom) for 1 h at 37°C. The cells were passed through a 40 μm cell strainer (Fisher Scientific, Loughborough, United Kingdom), which retained epithelial cells more resistant to enzymatic digestion. Ficoll-Paque PLUS (GE Healthcare, Little Chalfont, United Kingdom) was utilized to remove erythrocytes from the stromal cell fraction. Subsequently, SUSD2+ and SUSD2− cells were isolated using magnetic bead sorting, as detailed previously (Masuda et al., 2012). Briefly, up to 1 × 106 EnSC/100 μL of Magnetic Bead Buffer (0.5% BSA in PBS) were combined with 5 μL/1 × 106 cells phycoerythrin (PE) conjugated anti-human SUSD2 antibody (BioLegend, London, United Kingdom). After 20 min on ice, approximately 1 × 107 cells/80 μL of Magnetic Bead Buffer were incubated with anti-PE-magnetic-activated cell sorting MicroBeads (20 μL/1 × 107 cells; Miltenyi Biotec, United Kingdom) for another 20 min. Cell suspensions (up to 1 × 108 cells/500 μL of Magnetic Bead Buffer) were applied onto MS columns (Miltenyi Biotec) in a magnetic field, and washed multiple times with 500 μL of Magnetic Bead Buffer. SUSD2− cells passed freely through the column, whereas magnetically labeled SUSD2+ cells were retained. Following removal from the magnetic field, SUSD2+ cells were eluted from the columns with 1 mL of Magnetic Bead Buffer. Purified SUSD2− and SUSD2+ cells were expanded in DMEM/F12 with 10% DCC-FBS, 1% antibiotic-antimycotic solution (Invitrogen), 1% L-glutamine (Invitrogen), estradiol (1 nM; Sigma-Aldrich), insulin (2 μg/mL; Sigma-Aldrich), and basic fibroblast growth factor (10 ng/mL; Merck Millipore, Watford, United Kingdom). Decidualization experiments were carried out at passage 2. Briefly, paired SUSD2− and SUSD2 + cells were seeded 6-well plates at a density of 2 × 105 cells/well and decidualized when confluent with 0.5 mM 8-bromoadenosine cAMP (8-bromo-cAMP; Sigma-Aldrich) and 1 μM medroxyprogesterone acetate (MPA; Sigma-Aldrich) in phenol red-free DMEM/F12 containing 2% DCC-FBS, 1% antibiotic-antimycotic solution. The spent medium was collected every 48 h for analysis, stored at −80°C and the differentiation medium refreshed. Decidual status was confirmed using transcript levels of the decidual marker gene PRL.
Immunofluorescence
Immunostaining was completed at passage 1. Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) for 10 min and blocked with 3% BSA or 5% normal goat serum in PBS for 30 min. Cells were then incubated with an anti-human VAP-1 antibody (HPA000980, 1:100; Sigma Aldrich) for 1 h at room temperature, followed by incubation with Alexa Fluor 488 anti-rabbit secondary antibody for 1 h at RT (1:1000; Thermo Fisher Scientific). Slides were mounted with VECTASHIELD anti-fade mounting media with DAPI (Vector Laboratories) to visualize the nuclei. Images were captured using a Zeiss Laser Scanning Microscope LSM 510 at 60× magnification.
Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR)
Total RNA was extracted from EnSC and PVC cultures using RNA STAT-60 (AMS Biotechnology). Equal amounts of total RNA (1 μg) were treated with DNase and reverse transcribed using the QuantiTect Reverse Transcription Kit (Qiagen), and the resulting cDNA was used as template in RT-qPCR analysis. Detection of gene expression was performed with Power SYBR Green Master Mix (Thermo Fisher Scientific), and the 7500 Real-Time PCR System (Applied Biosystems). The expression levels of the samples were calculated using the ΔΔCt method, incorporating the efficiencies of each primer pair. The variances of input cDNA were normalized against the levels of the L19 housekeeping gene. All measurements were performed in triplicate. Melting curve analysis confirmed amplification specificity. Primer sequences used were as follows: AOC3, forward: TCC TGT GCC AGG ACT CTCTT and reverse CAA GGT TCA GTG TCC CCT GT; L19, forward: GCG GAA GGG TAC AGC CAA T and reverse: GCA GCC GGC GCA AA; PRL, sense 5′-AAG CTG TAG AGA TTG AGG AGC AAA C-3′, PRL antisense 5′-TCA GGA TGA ACC TGG CTG ACT A-3′.
Preparation of Spent Medium for Analysis
For untargeted exometabolome analysis, samples were prepared as described previously (Zhu et al., 2011; Cui et al., 2013) with some modifications. Briefly 50 μL of EnSC and PVC conditioned media were thawed at 4°C, and quality control (QC) samples were prepared by mixing an equal amount of conditioned media from each of the samples. Both QC and the conditioned media from PVC and EnSC were processed in the same way. Proteins were precipitated with 200 μL ice-cold methanol containing 10 μg/mL 9-fluorenylmethoxycarbonyl-glycine as an internal standard (ISTD), and vortexed. Following centrifugation at 16,000 rpm for 10 min at 4°C, the supernatant was collected and evaporated until dry in a speed vacuum evaporator then resuspended in 200 μL of water/methanol (98:2; v/v) for liquid chromatography-mass spectrometry (LC-MS) analysis. All samples were kept at 4°C and analyzed within 48 h. The sample run order was randomized to remove batch effects and the QC samples were analyzed after every eight samples to monitor the stability of the system.
Untargeted LC-MS Exometabolomics
Untargeted exometabolomics was performed as previously described (Cui et al., 2017). The prepared conditioned media was analyzed using Agilent 1290 ultrahigh-pressure liquid chromatography system (Waldbronn, Germany) equipped with a 6520 QTOF mass detector managed by a MassHunter workstation. The oven temperature was set at 45°C.
The 5 μL of injected sample was separated using an Agilent rapid resolution HT Zorbax SB-C18 column (2.1 × 50 mm, 1.8 mm; Agilent Technologies, Santa Clara, CA, United States), 0.4 mL/min flow rate, and a gradient elution involving a mobile phase consisting of (A) 0.1% formic acid in water and (B) 0.1% formic acid in methanol. To start the mobile phase was set at 5% B, with a 7-min linear gradient to 70% B, then a 12 min gradient to 100% B. This was held for 3 min then returned to 5% B in 0.1 min.
Both positive and negative electrospray ionization were used to collect mass data between m/z 100 and 1000 at a rate of two scans per second. The ion spray was set at 4,000 V, and the heated capillary temperature was maintained at 350°C. The drying gas and nebulizer nitrogen gas flow rates were 12.0 L/min and 50 psi, respectively. Two reference masses (m/z 121.0509 (C5H4N4) and m/z 922.0098 (C18H18O6N3P3F24) were continuously infused to the system to allow constant mass correction during the run.
Targeted LC-MS Exometabolomics
Adenosine, inosine, hypoxanthine, and xanthine were measured and analyzed by targeted LC-MS/MS analysis. The analysis was conducted as described previously with some modifications (Garcia-Manteiga et al., 2011). Briefly, LC-MS analysis was performed with Agilent 1290 ultrahigh-pressure liquid chromatography system (Waldbronn, Germany) coupled to an electrospray ionization with iFunnel Technology on an Agilent 6490 triple quadrupole mass spectrometer.
The auto-sampler was cooled at 4°C and 2 μL of injected sample was chromatographically separated using an Atlantis HILIC column (2.1 × 100 mm; Waters, Eschborn, Germany). The mobile phases were (A) 10 mM ammonium formate and 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile. Initially, 100% was utilized for 2 min, then reduced to 80% in a linear gradient for 11 min, and to 40% B over 1 min. This was held for 5 min and then the mobile phase was returned to starting conditions over 6 min. The column was kept at 45°C and the flow rate was 0.4 mL/min. Direct infusion of individual standard solutions allowed optimization of both the mass transition and collision energy for each compound by direct infusion. Both positive and negative electrospray ionization modes were performed with the following source parameters: drying gas temperature at 250°C with a flow of 14 L/min, sheath gas temperature at 400°C with a flow of 11 L/min, nebulizer gas pressure at 40 psi, capillary voltage 4,000 V and 3,500 V for positive and negative mode, respectively, and nozzle voltage 500 V for both positive and negative modes.
Data Analysis
Raw spectrometric data in untargeted metabolomics were analyzed by MassHunter Qualitative Analysis software (Agilent Technologies, United States). The Molecular Feature Extractor algorithm was used to obtain the molecular features, employing the retention time (RT), chromatographic peak intensity and accurate mass as input. Next, the features were analyzed by MassHunter Mass Profiler Professional software (Agilent Technologies, United States). Here, only features detected in at least 80% of the samples at the same sampling time point signal with an intensity ≥20,000 counts, three-times the limit of detection of the LC-MS instrument, were kept for further processing. Pre-statistical filtering of samples was performed, including the removal of samples with more than 60% missing data. One sample had 62% missing data and was subsequently removed from the untargeted analysis. The tolerance window for alignment of RT and m/z values was set at 0.15 min and 2 mDa, respectively, and the data normalized to the 9-fluorenylmethoxycarbonyl-glycine ISTD spike.
Raw spectrometric data in targeted metabolomics were processed using MassHunter Workstation Quantitative Analysis software (Agilent Technologies, United States). Missing values were imputed using half the lowest value. For both untargeted and targeted analysis, metabolites that were differentially expressed were inputted into the Metaboanalyst Pathway Analysis Tool to identify pathways that were altered during decidualization or between PVC and EnSC. This incorporates both pathway topology and enrichment analysis to output pathways that have changed significantly, and the pathway impact (Chong et al., 2019). The hypergeometric test was used and relative-betweenness centrality for over-representation analysis and pathway topology analysis, respectively. The pathway impact is calculated by the number of compounds that are significantly altered in relation to the total number of compounds in the pathway (Chong et al., 2019).
Statistical Analysis
For statistical analysis, non-parametric Test (Wilcoxon, Mann–Whitney test) with Holm-Sidak Multiple Testing Correction was employed and statistical significance was set at p < 0.05. For multivariate data analysis using hierarchical clustering or partial least squares regression (PLSR) analysis, data were normalized by applying log2, median-centering and dividing by standard deviation. Unsupervised Euclidean distance hierarchical clustering was performed using HemI (Deng et al., 2014). In addition, fold change (FC) analysis was performed to further filter the features and only those features with FC > 1.5 were selected as potential significantly altered metabolites across decidualization.
Compound Identification
The identification of the differential metabolites structure was based on our published work (Cui et al., 2017). Briefly, MassHunter software (Agilent) was used to calculate the elemental compositions of the metabolites based on their exact mass, the isotope pattern, and the nitrogen rule. The elemental composition in combination with the exact mass were used in open-source database searches, including HMDB1, LIPIDMAPS2, MassBank3, and METLIN4. Next, MS/MS experiments were performed to obtain structural information from the fragmentation pattern of the metabolite and these MS/MS spectra were searched and compared to compounds in the databases. Finally, the metabolites were confirmed by comparison with the standards where commercially available. The metabolites meet the minimum reporting standards for chemical analysis in metabolomics recommended by Metabolomics Standard Initiative (MSI) (Sumner et al., 2007).
Results
Exometabolic Footprints of Decidualizing Primary EnSC
The endometrial stromal fraction of 12 midluteal biopsies were separated into SUSD2+ PVC and SUSD2− EnSC by magnetic-activated cell sorting (MACS) (Figure 1). These cells were tested for AOC3/VAP-1 expression, as we have previously reported that AOC3 is highly enriched in PVC cells (Murakami et al., 2014). AOC3 mRNA levels were significantly enriched in freshly isolated PVC cells when compared to their EnSC counterparts (p = 0.0052; Figure 1B). Immunofluorescence showed VAP-1 immunoreactivity on the cell surface of SUSD2 + cells whereas more discrete, punctate cytoplasmic staining was observed in EnSC (Figure 1C and Supplementary Figures 1, 2). Both subpopulations were cultured to confluency and then decidualized over 8 days. Conditioned culture media of paired decidualizing PVC and EnSC cultures were collected every 48 h and subjected LC-MS based metabolomics.
Figure 1. Exometabolic footprints of decidualizing primary EnSC (A) Schematic representation of experimental design and the analytical process. Paired PVC and EnSC cultured were established from 12 endometrial biopsies. Conditioned media was collected from undifferentiated cultures (D0, day 0) and after 2, 4, and 8 days of decidualization. (B) Quantitative real-time PCR measuring AOC3 mRNA in PVC and EnSC. (C) Immunofluorescence staining of VAP-1 (green) in PVC and EnSC, following magnetic-activated sorting. DAPI (blue) was utilized to stain the nuclei. Pictures were taken at 60× magnification with a Zeiss Laser Scanning Microscope LSM 510. Scale bar represents 160 pixels. **p < 0.01.
A total of 145 annotated secreted metabolites and 5 unidentified metabolites were detected in the conditioned media of both PVC and EnSC (Supplementary Table 2). There were no metabolites unique to either PVC or EnSC. Hence, the metabolite data of PVC and EnSC were first combined to construct a temporal map of metabolic footprints associated with decidualization.
The QC samples clustered together in principal component analysis (PCA) scores plots (Supplementary Figure 3), indicating good stability and reproducibility of the chromatographic separation throughout the entire sequence. PLSR analysis separated the decidual time points into distinct groups (Figure 2A). Regression coefficients were used to identify metabolites that shaped the progression of decidualizing cells throughout the time-course. Metabolites with the five highest β-coefficient (β) at each timepoint are depicted in Figure 2B. Phenylalanyl-tyrosine (β: 0.02), 2,3-dinor-8-iso prostaglandin F2α (2,3-dinor-8-isoPGF2α) (β: 0.01), and hypoxanthine (β: 0.02) were identified, respectively, as influencers on day 0 (undifferentiated cells), day 2 and day 4 of the decidual time-course. Adenosine thiamine triphosphate (AThTP) (β: 0.01) and hyaluronic acid (β: 0.01) were the highest influencers of day 8 of decidualization.
Figure 2. Temporal exometabolome of EnSC. (A) Partial least squares regression (PLSR) analysis separated the exometabolomes according to decidual time-points. The secreted metabolite levels were log2 transformed, the data centered using median, and scaled by SD. (B) Metabolites with the top five PLSR regression coefficients across the decidual time-course.
The exometabolome analysis of conditioned media revealed a marked temporal change in metabolic footprints upon decidualization. Out of the 150 detected compounds, the secreted levels of 79 metabolites changed by 1.5-fold (p < 0.05) over the 8-day decidual time-course (Figure 3A and Supplementary Table 3). Unsupervised hierarchical clustering showed a major bifurcation in exometabolome profiles between undifferentiated and decidualizing cells. Further, each decidual time-point was characterized by a unique footprint, which supports the notion that decidualization is a multistep differentiation process (Figure 3A).
Figure 3. Exometabolic footprints of decidualizing primary EnSC. (A) Heatmap of differentially secreted metabolites across the time-course based on unsupervised Euclidean distance hierarchical clustering. (B) Representative metabolites altered upon decidualization. Data represent mean ± SD. N.D, not detected. Different letters above the SD indicates differential secretion at the indicated time-point (p < 0.05; t-test with Holm-Sidak correction). (C) MetaboAnalyst pathway analysis across decidualization in EnSC. The most enriched pathways include VLIB, valine, leucine, and isoleucine biosynthesis; GM, glycero-phospholipid metabolism; GSTM, glycine, serine, and threonine metabolism; PTTB, phenylalanine tyrosine and tryptophan biosynthesis; LM, linoleic acid metabolism; and PM, pyrimidine metabolism. Other pathways are numbered and tabulated in Supplementary Figure 5.
Figure 3B highlights several regulated secreted metabolites, some of which are already implicated in decidualization. For example, the prostaglandin metabolite, 2, 3-dinor-8-isoPGF2α, which can be derived from PGE2, was undetectable in undifferentiated cultures but consistently upregulated in differentiating cells throughout the decidual time-course. Secreted levels of glucosylsphingosine, a sphingolipid metabolite, followed the same pattern, in keeping with the dependency of the decidual process on de novo sphingolipid synthesis (Mizugishi et al., 2007; Ding et al., 2018). Several metabolites were selectively secreted by the decidualizing cells on day 8, including 5-amino-3-oxohexanoate and hyaluronic acid (HA). HA prevents apoptosis of decidual cells through binding to its receptor CD44 (Takizawa et al., 2014). 20-trihydroxy-leukotriene-B4 and PE (18:3/14:1) are examples of metabolites whose extracellular concentrations declined upon decidualization, whereas phosphatidylcholine (PC) (16:0/16:0) and lactosamine exemplify metabolites exhibiting a biphasic secreted pattern, peaking on day 2 and day 4 of decidualization, respectively. A difference in molecular mass distinguishes endogenous cyclic AMP levels which increased upon decidualization from the 8-bromo-cAMP utilized to stimulate decidualization.
Metaboanalyst was used to identify metabolic pathways regulated upon decidualization (Chong et al., 2019). Twenty-one metabolic pathways were identified across the decidual time-course (Supplementary Figure 4). As shown in Figure 3C, prominent pathways enriched across the decidual time-course included valine, leucine, and isoleucine biosynthesis (VLIB), glycerophospholipid metabolism (GM), and phenylalanine, tyrosine, and tryptophan metabolism (PTTM). Pyrimidine metabolism (PM) was enriched on day 8 of decidualization, suggesting the requirement for pyrimidines as nitrogenous bases in DNA and RNA.
Metabolites Differentially Secreted by Decidualizing PVC and EnSC
The temporal changes in the metabolic footprints of decidualizing PVC and EnSC were comparable but not identical, as demonstrated PLSR analysis (Supplementary Figure 5). Notably, apart from a single metabolite (N2, N2-Dimethylguanosine), no significant difference was observed in the exometabolomes of undifferentiated PVC and EnSC. By day 2 of decidualization, however, the secreted levels of 12 annotated metabolites were significantly higher in PVC compared to EnSC and 4 were lower (1.5 fold-change, p < 0.05; Supplementary Table 4). By day 4 and day 8 of decidualization, secreted levels of 6 and 9 metabolites, respectively, were significantly different between PVC and EnSC (Supplementary Table 4). Out of a total of 32 differentially secreted, annotated metabolites, 20 were more abundantly expressed by PVC. Figure 4A shows examples of metabolites differentially secreted between PVC and EnSC at each timepoint of the decidual pathway.
Figure 4. Metabolites differentially secreted by decidualizing PVC and EnSC. (A) Compounds significantly different between PVC and EnSC. Data represents mean ± SD. * indicates p < 0.05 (t-test with Holm-Sidak correction). (B) Metaboanalyst Pathway analysis comparing PVC to EnSC of untargeted metabolomics by for day 2, 4, and 8 decidualization. Pathways labeled: GSTM, glycine, serine, and threonine metabolism; VLIB, valine, leucine, and isoleucine biosynthesis; BM, biotin metabolism; TCA, tricarboxylic acid cycle; PyM, pyruvate metabolism; SM, sphingolipid metabolism; PPM, pentose phosphate metabolism; PPS, phosphatidylinositol signaling system; IPM, inositol phosphate metabolism; and PuM, purine metabolism. Other pathways, represented by numbers, can be found in Supplementary Figure 6.
To further elucidate the metabolic differences between PVC and EnSC upon decidualization, pathway enrichment analysis was performed (Figure 4B). Interestingly, distinct metabolomic profiles emerged. The tricarboxylic acid cycle (TCA), and glycine, serine and threonine metabolism (GSTM) were enriched in PVC cells on day 2 of decidualization. Enrichment of sphingolipid metabolism (SM) arose at in PVC at day 4, whereas inositol phosphate metabolism (IPM) and the pentose phosphate metabolism (PPM) were more prominent in EnSC. Finally, on day 8, sphingolipid (SM) and purine metabolism (PuM) were enriched in PVC. Purine metabolism had the highest pathway impact and significance (Figure 4B and Supplementary Figure 6), suggesting a greater autocrine or paracrine requirement of purine signaling upon decidualization in PVC when compared to EnSC.
Targeted Exometabolomic Analysis Validates Altered Purine Metabolite Secretion Upon Decidualization
The enrichment in purine metabolism (Figure 5A) prompted us to investigate its wider metabolomic network in greater depth. We developed an analytically robust targeted mass spectrometry analysis (average coefficient of variation = 23.9%) to assess adenosine, inosine, hypoxanthine, and xanthine levels. Adenosine (7.8 fold-change, p = 0.0001), inosine (1.53 fold-change, p < 0.02) and xanthine (3.1 fold-change, p = 0.0001) were significantly higher in PVC on day 8 of the decidual time-course in comparison to undifferentiated cells whereas uridine (0.21 fold-change, p < 0.0001) and cytidine (0.42 fold-change, p = 0.001) were significantly lower. Furthermore, xanthine levels were significantly lower in PVC compared to EnSC conditioned media in both undifferentiated and decidualized cultures (Figure 5B and Supplementary Table 5).
Figure 5. Targeted exometabolomic analysis validates altered purine metabolite secretion at day 8 of decidualization. (A) Schematic overview of the purine metabolic pathway. (B) Secreted purine metabolites were measured by targeted mass spectrometry in conditioned medium of paired PVC and EnSC cultures decidualized for 8 days. The data show the relative change in secreted metabolite levels in PVC compared to EnSC cultures. The data are mean ± SD and the individual data points show variability between paired cultures. * indicates p < 0.05 (t-test with Holm-Sidak correction).
Discussion
Several studies have documented the dynamic changes in the EnSC transcriptome, proteome and secretome upon decidualization (Garrido-Gomez et al., 2011; Murakami et al., 2014; Rytkönen et al., 2019), but changes in secreted metabolites that may function as signaling molecules have not yet been characterized. Understanding the niche signaling enhances our understanding of human implantation and pregnancy. Here, we demonstrate that decidualization of EnSC and PVC induces conspicuous metabolic footprints that are tightly regulated in a temporal fashion. For instance, HA secretion was prominent upon full decidualization (day 8) in both EnSC and PVC. This ECM macromolecule has gel properties and is typically highly expressed in rapidly expanding tissues (Karousou et al., 2017). The temporally restricted pattern of HA secretion upon decidualization, therefore, suggests a potential role in decidual expansion in early pregnancy. HA also binds CD44 expressed on extravillous trophoblast and vasculature, indicating a role in spiral artery remodeling (Takizawa et al., 2014). Moreover, loss of HA secretion has been linked to miscarriage (Takizawa et al., 2014), which further underscores the importance of appropriate temporospatial secretion of this ECM component in pregnancy.
Our untargeted analysis also revealed significant changes in secreted lipid metabolites upon decidualization. Phosphodimethyl-EA and PC (16:0/16:0) are present in phospholipid bilayers, act as signaling molecules, and contribute phosphoethanolamine and phosphocholine, respectively, to form sphingolipids such as sphingomyelin (Gault et al., 2010; Merrill, 2011; Furse and de Kroon, 2015). Decreasing levels of phosphodimethyl-EA, PC (16:0/16:0) upon decidualization occurred in concert with increased secretion of glucosylsphingosine, indicating a role for extracellular sphingolipids. Enhanced sphingolipid secretion corroborates recent findings from mice demonstrating that genes encoding sphingolipid producing enzymes are upregulated upon decidualization (Ding et al., 2018). Mice deficient in sphingolipid synthesizing enzymes exhibit impaired decidualization, reduced implantation sites, and vascular endothelial defects that compromise trophoblast from invading the maternal vasculature (Mizugishi et al., 2007; Ding et al., 2018). Sphingolipids play a role in angiogenesis and promote phospholipase A2 enzymatic activity, the enzyme required to form arachidonic acid, a precursor for prostaglandins and leukotrienes (Murakami and Kudo, 2002; Singh and Subbaiah, 2007). While 20-trihydroxyleukotriene secretion decreased upon decidualization, 2,3-dinor-8-isoPGF2α levels were consistently elevated across the time-course, suggesting that sustained de novo synthesis of sphingolipids is important for decidualization, as demonstrated in mice (Ding et al., 2018). Alterations in pyrimidine and glycerolipid metabolism coincides with morphological changes observed during decidualization. Enrichment of glycolipids metabolism across decidualization, a precursor to fatty acid production, is consistent with the accumulation of lipid droplets, a key energy store, upon decidualization (Guo et al., 2009; Kuroda et al., 2013; Gellersen and Brosens, 2014), whereas pyrimidines are required for nucleic acid production and as an energy carrier in differentiation (Lane and Fan, 2015).
Exometabolomic differences were also observed between PVC and EnSC. The most notable differences occurred on day 2 of decidualization, i.e., coinciding with the initial inflammatory phase (Salker et al., 2012; Stadtmauer and Wagner, 2020). The secreted response at this time-point was also more pronounced in PVC than EnSC, in keeping with the topology of decidualization in vivo (Murakami et al., 2014). The PVC exometabolome on day 2 was enriched in higher energy metabolites linked to pyruvate metabolism and TCA cycle, indicative of Warburg effect or active metabolism (DeBerardinis and Chandel, 2020). On day 8 of the decidual time-course, the PVC exometabolome was enriched for other metabolites, such as sphingolipids and purines involved in signaling and structural integrity (Merrill, 2011; Linden et al., 2019).
Purines, along with pyrimidines, stimulate purinergic receptors, which belong to two subfamilies, the P2X and P2Y receptors (P2XR and P2YR, respectively). P2XR are plasma membrane channels that increase cytosolic Ca2+ concentration and mediate the flux of K+ and Na+ upon activation (di Virgilio and Adinolfi, 2017). P2 × 4R is linked to PGE2 signaling (Ulmann et al., 2010). P2YR are G-protein coupled receptors that modulate Ca2+ mobilization and cAMP signaling in response to either the pyrimidines adenine and uridine, or purines. The affinity for different ligands varies between receptors; for example, P2Y2R preferentially binds UTP, whereas P2Y11R binds ATP (Giuliani et al., 2019).
Purines modulate cell growth, act as coenzymes, and are a source of energy whereas pyrimidines contribute to phospholipid biosynthesis, glycosylation and detoxification (Löffler et al., 2005; Yin et al., 2018). Not only do endometrial cells, and particularly epithelial cells, express purinergic receptors but placental trophoblast expresses nearly the entire repertoire of purinergic receptors (Roberts et al., 2006, 2007; Burnstock, 2014). Thus, purine and pyrimidine nucleotides potentially act as metabolic signals acting on the purinergic receptors at the placental-decidual interface. In concurrence, purine derivatives are over-represented in bovine conceptus elongation, further emphasizing the importance of purines in conceptus development (Simintiras et al., 2019).
Intriguingly, purine levels correlate with the induction of stress ligands expression, such as the cell surface glycoprotein MHC class I polypeptide-related sequence A (MICA), a ligand for the natural killer group 2D receptor (NKG2D) (McCarthy et al., 2018). Recently, uNK cells were shown to target and eliminate senescent decidual cells through activation of NKG2D receptors (Brighton et al., 2017; Lucas et al., 2020), a process that is purportedly essential to prevent chronic senescence of the placental-decidual interface in pregnancy, leading to tissue breakdown and miscarriage (Lucas et al., 2020).
Targeted LC-MS demonstrated markedly lower levels of xanthine in PVC compared to EnSC, irrespective of decidualization. By contrast, decidualized PVC secreted higher levels of adenosine and inosine. Adenosine is an anti-inflammatory metabolite and stress signal (Kaster et al., 2013), and precursor to inosine. Inosine, an immunomodulator, is exported from cells through nucleoside transporters when intracellular concentrations are high (Kaster et al., 2013). Extracellular inosine signals through adenosine receptors and is broken down to form the downstream metabolite hypoxanthine. Xanthine is formed during the breakdown of hypoxanthine by xanthine dehydrogenase (XDH). In keeping with our observations, XDH transcript levels are significantly lower in PVC compared to EnSC (Murakami et al., 2014). Lower xanthine secretion by PVC suggests that higher energy purines are important in the perivascular niche as hypoxanthine is readily available to form inosine, a paracrine signaling molecule that can be recycled back to produce upstream metabolites, such as ATP. Extracellular release of ATP can induce a pro-inflammatory state, regulate the binding activity of estrogen receptors, increase production of reactive oxygen species, and induce metalloproteinase expression (Chang et al., 2007; Cruz et al., 2007; Cekic and Linden, 2016). Furthermore, ATP has been shown to promote IL-8 secretion in endometrial epithelial cells and stimulate decidualization (Gu et al., 2020). Thus, redirecting hypoxanthine toward the upstream purines may represent a mechanism to heighten decidualization of PVC cells. Taken together, the data suggest that a balance and switch between ATP, a mainly proinflammatory molecule, and adenosine, an anti-inflammatory factor, is required for an effective decidual response. Our results reflect the exometabolomic footprint of decidualizing cells from women with fertility issues. Evaluation of other samples, including women with normal reproductive histories, are required to test generalizability. In summary, this study is the first to map the temporally resolved exometabolome changes in differentiating human EnSC and to highlight the potential of secreted metabolites acting as autocrine or paracrine signaling molecules as the decidual process unfolds. Although the overall temporal change in metabolic footprints was remarkably consistent between decidualizing PVC and EnSC, differential secretion of specific metabolites not only reflects metabolic differences between stromal subpopulations but also raises the possibility of spatial organization of metabolic cues at the decidual-placental interface.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.
Ethics Statement
The studies involving human participants were reviewed and approved by the NHS National Research Ethics – Hammersmith and Queen Charlotte’s and Chelsea Research Ethics Committee (1997/5065). The patients/participants provided their written informed consent to participate in this study.
Author Contributions
YL: conceptualization. JZ, SG, MD, EL, LC, and KM: research. YL, JB, and QC: resources and supervision. SH: data analysis. SH, YL, and JB: writing. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding
This study was supported by the National Research Foundation Singapore under its NMRC Centre Grant Program (NMRC/CG/M003/2017), National Research Foundation Singapore Fellowship (NRF-NRFF2017-03) to QC, and Wellcome Trust Investigator Award to JB (212233/Z/18/Z). SH was funded by the University of Warwick Medical School and A∗STAR, Singapore as part of the A∗STAR Research Attachment Program.
Acknowledgments
We thank participating patients for donating endometrial samples. We are indebted to Drs. Siobhan Quenby and Lauren Lacey and the staff of the Biomedical Research Unit at University Hospitals Coventry and Warwickshire NHS Trust for their help with sample collection. This article was submitted following preprint on BioRxiv (doi: https://doi.org/10.1101/2020.08.06.221119) (Harden et al., 2020).
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2021.626619/full#supplementary-material
Footnotes
- ^ http://www.hmdb.ca/
- ^ http://www.lipidmaps.org/
- ^ http://www.massbank.jp/
- ^ http://metlin.scripps.edu/
References
Al-Sabbagh, M., Fusi, L., Higham, J., Lee, Y., Lei, K., Hanyaloglu, A. C., et al. (2011). NADPH oxidase-derived reactive oxygen species mediate decidualization of human endometrial stromal cells in response to cyclic AMP signaling. Endocrinology 152, 730–740. doi: 10.1210/en.2010-0899
Armulik, A., Genové, G., and Betsholtz, C. (2011). Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215. doi: 10.1016/j.devcel.2011.07.001
Berkhout, R. P., Lambalk, C. B., Huirne, J., Mijatovic, V., Repping, S., Hamer, G., et al. (2018). High-quality human preimplantation embryos actively influence endometrial stromal cell migration. J. Assist. Reprod. Genet. 35, 659–667. doi: 10.1007/s10815-017-1107-z
Birkenstock, T., Liebeke, M., Winstel, V., Krismer, B., Gekeler, C., Niemiec, M. J., et al. (2012). Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens. J. Biol. Chem. 287, 2887–2895. doi: 10.1074/jbc.M111.288894
Brighton, P. J., Maruyama, Y., Fishwick, K., Vrljicak, P., Tewary, S., Fujihara, R., et al. (2017). Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium. eLife 6:e31274. doi: 10.7554/eLife.31274.001
Brosens, J. J., Parker, M. G., McIndoe, A., Pijnenborg, R., and Brosens, I. A. (2009). A role for menstruation in preconditioning the uterus for successful pregnancy. Am. J. Obstet. Gynecol. 200, 615.e1–615.e6. doi: 10.1016/j.ajog.2008.11.037
Brosens, J. J., Salker, M. S., Teklenburg, G., Nautiyal, J., Salter, S., Lucas, E. S., et al. (2014). Uterine selection of human embryos at implantation. Sci. Rep. 4:3894. doi: 10.1038/srep03894
Burnstock, G. (2014). Purinergic signalling in the reproductive system in health and disease. Purinergic Signal. 10, 157–187. doi: 10.1007/s11302-013-9399-7
Cekic, C., and Linden, J. (2016). Purinergic regulation of the immune system. Nat. Rev. Immunol. 16, 177–192. doi: 10.1038/nri.2016.4
Chang, S.-J., Wang, T.-Y., Lee, Y.-H., and Tai, C.-J. (2007). Extracellular ATP activates nuclear translocation of ERK1/2 leading to the induction of matrix metalloproteinases expression in human endometrial stromal cells. J. Endocrinol. 193, 393–404. doi: 10.1677/JOE-06-0168
Chong, J., Wishart, D. S., and Xia, J. (2019). Using metaboanalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr. Protoc. Bioinform. 68:e86. doi: 10.1002/cpbi.86
Cloke, B., Huhtinen, K., Fusi, L., Kajihara, T., Yliheikkilä, M., Ho, K. K., et al. (2008). The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinology 149, 4462–4474. doi: 10.1210/en.2008-0356
Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L. M., Persechini, P. M., and Ojcius, D. M. (2007). ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282, 2871–2879. doi: 10.1074/jbc.M608083200
Cui, L., Fang, J., Ooi, E. E., and Lee, Y. H. (2017). Serial metabolome changes in a prospective cohort of subjects with influenza viral infection and comparison with dengue fever. J. Proteome Res. 16, 2614–2622. doi: 10.1021/acs.jproteome.7b00173
Cui, L., Lee, Y. H., Kumar, Y., Xu, F., Lu, K., Ooi, E. E., et al. (2013). Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl. Trop. Dis. 7:e0002373. doi: 10.1371/journal.pntd.0002373
Cui, L., Lu, H., and Lee, Y. H. (2018). Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Mass Spectrom. Rev. 37, 772–792. doi: 10.1002/mas.21562
DeBerardinis, R. J., and Chandel, N. S. (2020). We need to talk about the Warburg effect. Nat. Metab. 2, 127–129. doi: 10.1038/s42255-020-0172-2
Deng, W., Wang, Y., Liu, Z., Cheng, H., and Xue, Y. (2014). HemI: a toolkit for illustrating heatmaps. PLoS One 9:e111988. doi: 10.1371/journal.pone.0111988
di Virgilio, F., and Adinolfi, E. (2017). Extracellular purines, purinergic receptors and tumor growth. Oncogene 36, 293–303. doi: 10.1038/onc.2016.206
Ding, N. Z., Qi, Q. R., Gu, X. W., Zuo, R. J., Liu, J., and Yang, Z. M. (2018). De novo synthesis of sphingolipids is essential for decidualization in mice. Theriogenology 106, 227–236. doi: 10.1016/j.theriogenology.2017.09.036
Emera, D., Romero, R., and Wagner, G. (2012). The evolution of menstruation: a new model for genetic assimilation: explaining molecular origins of maternal responses to fetal invasiveness. BioEssays 34, 26–35. doi: 10.1002/bies.201100099
Erkenbrack, E. M., Maziarz, J. D., Griffith, O. W., Liang, C., Chavan, A. R., Nnamani, M. C., et al. (2018). The mammalian decidual cell evolved from a cellular stress response. PLoS Biol. 16:e2005594. doi: 10.1371/journal.pbio.2005594
Erlebacher, A. (2013). Immunology of the maternal-fetal interface. Annu. Rev. Immunol. 31, 387–411. doi: 10.1146/annurev-immunol-032712-100003
Ferland-McCollough, D., Slater, S., Richard, J., Reni, C., and Mangialardi, G. (2017). Pericytes, an overlooked player in vascular pathobiology. Pharmacol. Ther. 171, 30–42. doi: 10.1016/j.pharmthera.2016.11.008
Ferreiro-Vera, C., Mata-Granados, J. M., Priego-Capote, F., Quesada-Gómez, J. M., and Luque De Castro, M. D. (2011). Automated targeting analysis of eicosanoid inflammation biomarkers in human serum and in the exometabolome of stem cells by SPE-LC-MS/MS. Anal. Bioanal. Chem. 399, 1093–1103. doi: 10.1007/s00216-010-4400-6
Furse, S., and de Kroon, A. I. P. M. (2015). Phosphatidylcholines functions beyond that of a membrane brick. Mol. Membr. Biol. 32, 117–119. doi: 10.3109/09687688.2015.1066894
Garcia-Manteiga, J. M., Mari, S., Godejohann, M., Spraul, M., Napoli, C., Cenci, S., et al. (2011). Metabolomics of B to plasma cell differentiation. J. Proteome Res. 10, 4165–4176. doi: 10.1021/pr200328f
Garrido-Gomez, T., Dominguez, F., Lopez, J. A., Camafeita, E., Quiñonero, A., Martinez-Conejero, J. A., et al. (2011). Modeling human endometrial decidualization from the interaction between proteome and secretome. J. Clin. Endocrinol. Metab. 96, 706–716. doi: 10.1210/jc.2010-1825
Gault, C. R., Obeid, L. M., and Hannun, Y. A. (2010). An overview of sphingolipid metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 688, 1–23. doi: 10.1007/978-1-4419-6741-1_1
Gellersen, B., and Brosens, J. J. (2014). Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr. Rev. 35, 851–905. doi: 10.1210/er.2014-1045
Giuliani, A. L., Sarti, A. C., and di Virgilio, F. (2019). Extracellular nucleotides and nucleosides as signalling molecules. Immunol. Lett. 205, 16–24. doi: 10.1016/j.imlet.2018.11.006
Gu, X. W., Yang, Y., Li, T., Chen, Z. C., Fu, T., Pan, J. M., et al. (2020). ATP mediates the interaction between human blastocyst and endometrium. Cell Prolif. 53:e12737. doi: 10.1111/cpr.12737
Guo, Y., Cordes, K. R., Farese, R. v., and Walther, T. C. (2009). Lipid droplets at a glance. J. Cell Sci. 122, 749–752. doi: 10.1242/jcs.037630
Harden, S. L., Zhou, J., Diniz-da-Costa, M., Lucas, E. S., Liang, C., Murakami, K., et al. (2020). Exometabolomic analysis of decidualizing human endometrial stromal and perivascular cells. BioRxiv [preprint]. doi: 10.1101/2020.08.06.221119v1
Kajihara, T., Jones, M., Fusi, L., Takano, M., Feroze-Zaidi, F., Pirianov, G., et al. (2006). Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol. Endocrinol. 20, 2444–2455. doi: 10.1210/me.2006-0118
Karousou, E., Misra, S., Ghatak, S., Dobra, K., Götte, M., Vigetti, D., et al. (2017). Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. Matrix Biol. 59, 3–22. doi: 10.1016/j.matbio.2016.10.001
Kaster, M. P., Budni, J., Gazal, M., Cunha, M. P., Santos, A. R. S., and Rodrigues, A. L. S. (2013). The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A2A receptors. Purinergic Signal. 9, 481–486. doi: 10.1007/s11302-013-9361-8
Kuroda, K., Venkatakrishnan, R., Salker, M. S., Lucas, E. S., Shaheen, F., Kuroda, M., et al. (2013). Induction of 11β-HSD 1 and activation of distinct mineralocorticoid receptor- and glucocorticoid receptor-dependent gene networks in decidualizing human endometrial stromal cells. Mol. Endocrinol. 27, 192–202. doi: 10.1210/me.2012-1247
Lane, A., and Fan, T. (2015). Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 43, 2466–2485. doi: 10.1093/nar/gkv047
Leitao, B., Jones, M. C., Fusi, L., Higham, J., Lee, Y., Takano, M., et al. (2010). Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals. FASEB J. 24, 1541–1551. doi: 10.1096/fj.09-149153
Linden, J., Koch-Nolte, F., and Dahl, G. (2019). Purine release, metabolism, and signaling in the inflammatory response. Annu. Rev. Immunol. 37, 325–347. doi: 10.1146/annurev-immunol-051116-052406
Löffler, M., Fairbanks, L. D., Zameitat, E., Marinaki, A. M., and Simmonds, H. A. (2005). Pyrimidine pathways in health and disease. Trends Mol. Med. 11, 430–437. doi: 10.1016/j.molmed.2005.07.003
Lucas, E. S., Dyer, N. P., Murakami, K., Hou Lee, Y., Chan, Y. W., Grimaldi, G., et al. (2016). Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells 34, 346–356. doi: 10.1002/stem.2222
Lucas, E. S., Vrljicak, P., Muter, J., Diniz-da-Costa, M. M., Brighton, P. J., Kong, C. S., et al. (2020). Recurrent pregnancy loss is associated with a pro-senescent decidual response during the peri-implantation window. Commun. Biol. 3, 1–14. doi: 10.1038/s42003-020-0763-1
Macklon, N. S., and Brosens, J. J. (2014). The human endometrium as a sensor of embryo quality1. Biol. Reprod. 91, 98–99. doi: 10.1095/biolreprod.114.122846
Masuda, H., Anwar, S. S., Bühring, H. J., Rao, J. R., and Gargett, C. E. (2012). A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant. 21, 2201–2214. doi: 10.3727/096368911X637362
Matta, P., Sherrod, S. D., Marasco, C. C., Moore, D. J., McLean, J. A., and Weitkamp, J.-H. (2017). In utero exposure to histological chorioamnionitis primes the exometabolomic profiles of preterm CD4 + T lymphocytes. J. Immunol. 199, 3074–3085. doi: 10.4049/jimmunol.1601880
Mazur, E. C., Vasquez, Y. M., Li, X., Kommagani, R., Jiang, L., Chen, R., et al. (2015). Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells. Endocrinology 156, 2239–2253. doi: 10.1210/en.2014-1566
McCarthy, M. T., Moncayo, G., Hiron, T. K., Jakobsen, N. A., Valli, A., Soga, T., et al. (2018). Purine nucleotide metabolism regulates expression of the human immune ligand MICA. J. Biol. Chem. 293, 3913–3924. doi: 10.1074/jbc.M117.809459
Merrill, A. H. (2011). Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111, 6387–6422. doi: 10.1021/cr2002917
Mizugishi, K., Li, C., Olivera, A., Bielawski, J., Bielawska, A., Deng, C. X., et al. (2007). Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. J. Clin. Investig. 117, 2993–3006. doi: 10.1172/JCI30674
Murakami, K., Lee, Y. H., Lucas, E. S., Chan, Y.-W., Durairaj, R. P., Takeda, S., et al. (2014). Decidualization induces a secretome switch in perivascular niche cells of the human endometrium. Endocrinology 155, 4542–4553. doi: 10.1210/en.2014-1370
Murakami, M., and Kudo, I. (2002). Phospholipase A2. J. Biochem. 131, 285–292. doi: 10.1093/oxfordjournals.jbchem.a003101
Muter, J., Alam, M. T., Vrljicak, P., Barros, F. S. V., Ruane, P. T., Ewington, L. J., et al. (2018). The glycosyltransferase EOGT regulates adropin expression in decidualizing human endometrium. Endocrinology 159, 994–1004. doi: 10.1210/en.2017-03064
Muter, J., Brighton, P. J., Lucas, E. S., Lacey, L., Shmygol, A., Quenby, S., et al. (2016). Progesterone-dependent induction of phospholipase C-related catalytically inactive protein 1 (PRIP-1) in decidualizing human endometrial stromal cells. Endocrinology 157, 2883–2893. doi: 10.1210/en.2015-1914
Nancy, P., Tagliani, E., Tay, C. S., Asp, P., Levy, D. E., and Erlebacher, A. (2012). Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336, 1317–1321. doi: 10.1126/science.1220030
Roberts, V. H. J., Greenwood, S. L., Elliott, A. C., Sibley, C. P., and Waters, L. H. (2006). Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1374–R1386. doi: 10.1152/ajpregu.00612.2005
Roberts, V. H. J., Waters, L. H., and Powell, T. (2007). Purinergic receptor expression and activation in first trimester and term human placenta. Placenta 28, 339–347. doi: 10.1016/j.placenta.2006.04.007
Rytkönen, K. T., Erkenbrack, E. M., Poutanen, M., Elo, L. L., Pavlicev, M., and Wagner, G. P. (2019). Decidualization of human endometrial stromal fibroblasts is a multiphasic process involving distinct transcriptional programs. Reprod. Sci. 26, 323–336. doi: 10.1177/1933719118802056
Ryu, M., Seo, B., Choi, Y., Han, M., Choi, Y., Chung, M., et al. (2020). Mitochondrial and metabolic dynamics of endometrial stromal cells during the endometrial cycle. Stem Cells Dev. 29, 1407–1415. doi: 10.1089/scd.2020.0130
Salker, M. S., Nautiyal, J., Steel, J. H., Webster, Z., Šućurović, S., Nicou, M., et al. (2012). Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One 7:e52252. doi: 10.1371/journal.pone.0052252
Simintiras, C. A., Sánchez, J. M., McDonald, M., and Lonergan, P. (2019). The biochemistry surrounding bovine conceptus elongation. Biol. Reprod. 101, 328–337. doi: 10.1093/biolre/ioz101
Singh, D. K., and Subbaiah, P. V. (2007). Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids. J. Lipid Res. 48, 683–692. doi: 10.1194/jlr.M600421-JLR200
Stadtmauer, D. J., and Wagner, G. P. (2020). Cooperative inflammation: the recruitment of inflammatory signaling in marsupial and eutherian pregnancy. J. Reprod. Immunol. 137:102626. doi: 10.1016/j.jri.2019.102626
Su, Q., Guan, T., and Lv, H. (2016). Siderophore biosynthesis coordinately modulated the virulence-associated interactive metabolome of uropathogenic Escherichia coli and human urine. Sci. Rep. 6:24099. doi: 10.1038/srep24099
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., et al. (2007). Proposed minimum reporting standards for chemical analysis: chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211–221. doi: 10.1007/s11306-007-0082-2
Takano, M., Lu, Z., Goto, T., Fusi, L., Higham, J., Francis, J., et al. (2007). Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol. Endocrinol. 21, 2334–2349. doi: 10.1210/me.2007-0058
Takizawa, T., Takahashi, H., Takizawa, T., Matsubara, S., Ohkuchi, A., Kuwata, T., et al. (2014). Extravillous trophoblast cell invasion is promoted by the CD44-hyaluronic acid interaction. Placenta 35, 163–170. doi: 10.1016/j.placenta.2013.12.009
Teklenburg, G., Salker, M., Molokhia, M., Lavery, S., Trew, G., Aojanepong, T., et al. (2010). Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One 5:e10258. doi: 10.1371/journal.pone.0010258
Ulmann, L., Hirbec, H., and Rassendren, F. (2010). P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 29, 2290–2300. doi: 10.1038/emboj.2010.126
Vrljicak, P., Lucas, E. S., Lansdowne, L., Lucciola, R., Muter, J., Dyer, N. P., et al. (2018). Analysis of chromatin accessibility in decidualizing human endometrial stromal cells. FASEB J. 32, 2467–2477. doi: 10.1096/fj.201701098R
Weimar, C. H. E., Kavelaars, A., Brosens, J. J., Gellersen, B., de Vreeden-Elbertse, J. M. T., Heijnen, C. J., et al. (2012). Endometrial stromal cells of women with recurrent miscarriage fail to discriminate between high- and low-quality human embryos. PLoS One 7:e41424. doi: 10.1371/journal.pone.0041424
Yin, J., Ren, W., Huang, X., Deng, J., Li, T., and Yin, Y. (2018). Potential mechanisms connecting purine metabolism and cancer therapy. Front. Immunol. 9:1697. doi: 10.3389/fimmu.2018.01697
Zhu, W., Stevens, A. P., Dettmer, K., Gottfried, E., Hoves, S., Kreutz, M., et al. (2011). Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 401, 3249–3261. doi: 10.1007/s00216-011-5436-y
Keywords: endometrium, decidualization, exometabolome, metabolism, perivascular cells, reproduction, endometrial stromal cells
Citation: Harden SL, Zhou J, Gharanei S, Diniz-da-Costa M, Lucas ES, Cui L, Murakami K, Fang J, Chen Q, Brosens JJ and Lee YH (2021) Exometabolomic Analysis of Decidualizing Human Endometrial Stromal and Perivascular Cells. Front. Cell Dev. Biol. 9:626619. doi: 10.3389/fcell.2021.626619
Received: 06 November 2020; Accepted: 11 January 2021;
Published: 28 January 2021.
Edited by:
Biserka Mulac Jericevic, University of Rijeka, CroatiaReviewed by:
Maximilian Schuff, NEXTCLINIC IVF Zentren Prof. Zech, AustriaPhilippa Saunders, University of Edinburgh, United Kingdom
Bruno Miguel Fonseca, University of Porto, Portugal
Copyright © 2021 Harden, Zhou, Gharanei, Diniz-da-Costa, Lucas, Cui, Murakami, Fang, Chen, Brosens and Lee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yie Hou Lee, yiehou.lee@smart.mit.edu
†These authors have contributed equally to this work